Stockscreener 앱 받기
121.83
0.64%
-0.79
시장 영업 전:
123.09
1.26
+1.03%
전일 마감가:
$122.62
열려 있는:
$123.43
하루 거래량:
10.40M
Relative Volume:
1.13
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.75%
1개월 성능:
-0.84%
6개월 성능:
+29.44%
1년 성능:
+41.71%
1일 변동 폭
$120.97
$124.91
1주일 범위
$120.97
$129.11
52주 변동 폭
$66.66
$132.09
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
121.83 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
662.29 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
665.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.72 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf 주식(XBI)의 최신 뉴스
XBI ETF: Biotech M&A Has Been Hot, But Price Trends Have Cooled (NYSEARCA:XBI) - Seeking Alpha
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Jensen Has the Ball: Will Nvidia GTC AI Be a Market Buzzer-Beater? - Investing.com
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
Should You Consider Putting Money into the VanEck Biotech ETF (BBH)? - Bitget
JPMorgan (AMJB) prices callable contingent‑interest notes linked to SCZ/XBI/KRE - Stock Titan
State Street SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofPTC Therapeutics (NASDAQ:PTCT) - Benzinga
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares? - Bitget
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Moderna, Mexico Partner To Boost Local Vaccine ProductionModerna (NASDAQ:MRNA) - Benzinga
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors - Defense World
These Three Biotechs Have the Right Mix as the Industry Gains - TheStreet Pro
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Biotech ETF (XBI) Hits New 52-Week High - TradingView
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg
Stock Market Today: Dow gains 250 points, S&P 500 and Nasdaq advance after Trump’s Greenland pivot boosts risk appetite - MarketWatch
Moderna Stock Explodes To New 52-Week High: What's Driving The Action? - Benzinga
2025 ETF Wrap-Up And What To Expect In 2026 - Seeking Alpha
Should you invest in the State Street SPDR S&P Biotech ETF (XBI)? - MSN
U.S. Biotech Rebound in 2026: IPOs, Deals & Policy Clarity Drive OptimismNews and Statistics - IndexBox
Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84% - Intellectia AI
US Biotech Share Sales Deliver Biggest First Week Since 2021 - Bloomberg
‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Equity Markets Rally, Commodities Decline as ETF Investors Optimize Portfolios for 2026 - Bitget
Equities Surge, Commodities Sink As ETF Investors Plan 2026Vanguard S&P 500 ETF (ARCA:VOO) - Benzinga
As Artificial Intelligence Stocks Surge in Value, Health Care ETFs Take Center Stage for Growth - Bitget
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Biotech and pharma stocks tumble as investors race into energy - MSN
Biotech and Pharma Stocks Tumble as Investors Race into Energy - Barron's
Biotech: Time For A Pause To Start 2026 - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - sharewise.com
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood - Seeking Alpha
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - MSN
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Look What I Found While Bargain Hunting in the Biotech Sector - TheStreet Pro
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026 - Benzinga
If You Invested $100 In State Street SPDR S&P Biotech ETF Stock 20 Years Ago, You Would Have This Much Today - Benzinga
State Street Spdr S P Biotech Etf (XBI) 재무 분석
State Street Spdr S P Biotech Etf (XBI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.14%
1.12%
자본화:
|
볼륨(24시간):